AbelZeta Pharma is a global cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs across hematologic malignancies, inflammatory and immunological diseases and solid tumors.Partners: AstraZeneca, Janssen (J&J), NovartisInvestors: HSG, Yunfeng Capital, GIC, TF Capital, CICC Capital, Sailing Capital, Dangdai Group, AstraZeneca-CICC Fund17